Andrew Walden
Company Director,
Royal Berkshire NHS Foundation Trust
Dr Andrew Walden has been an NHS consultant in Acute Medicine and Intensive Care Medicine for over 10 years. He has widespread experience of Point of Care diagnostics having developed national competencies for Point of Care Ultrasound and has published widely around the topic both in this country and in resource poor settings, worldwide. He is a strong advocate of precision diagnostics in acutely unwell patients as he believes that this leads to better triage, management and outcomes. To this end he has championed the use of Point of Care molecular testing for rapid diagnosis in sepsis.
